Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Prostatic Neoplasms × Radiotherapy × Clear all

Status

Sponsor Class

OTHER 121 NETWORK 16 NIH 7 INDUSTRY 6 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Glioblastoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Pulmonary Fibrosis 1 Prostatic Neoplasms 1 Ototoxicity 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Ketosis 1 Insulin Resistance 1 Hearing Loss 1 Glioma 1 Germinoma 1 Esophageal Squamous Cell Carcinoma 1 Cognitive Dysfunction 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 3 Zoledronic Acid 3 enzalutamide 2 Magnetic Resonance Spectroscopy 2 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 2 Androgen Antagonists 2 Abiraterone Acetate 2 darolutamide 1 apalutamide 1 abiraterone 1 Watchful Waiting 1 Urination 1 Transurethral Resection of Prostate 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Single Photon Emission Computed Tomography Computed Tomography 1 Rehabilitation 1 Radiotherapy 1 Radiosurgery 1 Prednisone 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Multiparametric Magnetic Resonance Imaging 1 Metformin 1 Magnetic Resonance Imaging 1 Finasteride 1 Everolimus 1 Dutasteride 1 Docetaxel 1 Culture Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06687421 2025-09-03

SPRINTR-REAL

Region Västerbotten

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡